1 of 3 listed pharmas making net profit/sales ratio even less than 1%
The polarization in profitability is reportedly getting serious as one of 3 listed pharmaceutical companies have a net profit ratio to sales less than 1%.
Yakup Shinmoon(www.yakup.com) analyzed 2017 audit reports that KOSPI and KOSDAQ listed pharmaceutical companies turned in, and the analysis s...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
